'Treasure in saliva' may reveal deadly diseases early enough to treat them

October 29, 2014

UCLA research could lead to a simple saliva test capable of diagnosing -- at an early stage -- diabetes and cancer, and perhaps neurological disorders and autoimmune diseases.

The study, the most comprehensive analysis ever conducted of RNA molecules in human saliva, reveals that saliva contains many of the same disease-revealing molecules that are contained in blood. It was published online today by the peer-reviewed journal Clinical Chemistry and will be published in the journal's January 2015 special print issue, "Molecular Diagnostics: A Revolution in Progress."

"If we can define the boundaries of molecular targets in saliva, then we can ask what the constituents in saliva are that can mark someone who has pre-diabetes or the early stages of oral cancer or pancreatic cancer -- and we can utilize this knowledge for personalized medicine," said Dr. David Wong, a senior author of the research and UCLA's Felix and Mildred Yip Endowed Professor in Dentistry.

Wong said the test also holds promise for diagnosing Type 2 diabetes, gastric cancer and other diseases. "If you don't look in saliva, you may miss important indicators of disease," Wong said. "There seems to be treasure in saliva, which will surprise people."

RNA, widely known as a cellular messenger that makes proteins and carries out DNA's instructions to other parts of the cell, is now understood to perform sophisticated chemical reactions and is believed to perform an extraordinary number of other functions, at least some of which are unknown.

Wong's research over the past decade has focused on identifying biomarkers in saliva. His laboratory discovered that some of the same RNA that is inside human cells are also present in saliva and can be used to detect diseases -- a surprising finding, he said, because enzymes in saliva can degrade RNA, making the mouth "a hostile environment."

The new research is a collaboration with Xinshu (Grace) Xiao, the paper's other senior author and a UCLA associate professor of integrative biology and physiology. Using state-of-the-science genomics and bioinformatics, the researchers analyzed 165 million genetic sequences.

Among the many forms of RNA are some unusual ones that live in the mouth and in cells. For example, it wasn't known until very recently that RNA comes in a circular form; the linear form has long been known. But the UCLA scientists identified more than 400 circular RNAs in human saliva -- the first discovery of circular RNA in saliva or any body fluid -- including 327 forms that were previously unknown.

Circular RNA's function in saliva is not entirely understood, although it does serve as a sponge for tiny RNA molecules called microRNAs, which bind to it.

"Circular RNAs in saliva may be protecting other RNAs," said Xiao, who also is a faculty member in the UCLA College and a member of UCLA's Molecular Biology Institute. It's likely, she said, that circular RNAs in saliva protect microRNAs from being degraded.

MicroRNAs, which once seemed to be little more than molecular noise, play important roles in many cell types, and have been implicated in cancers and other diseases, Xiao said. One microRNA can regulate hundreds of genes, she said.

The scientists compared microRNA levels in saliva to those in the blood and other body fluids, and found the levels of microRNA in blood and in saliva are very similar -- indicating that a saliva sample would be a good measure of microRNAs in the body.

They also found that saliva contains another class of small RNAs, called piwi-interacting RNAs, or piRNAs, which are produced by stem cells, skin cells and germ cells. There are very few piRNAs in blood and most other body fluids, but Xiao's analysis showed that piRNA are abundant in saliva. Although their function is not yet known, Xiao said they may protect the body from viral infection.

While most RNA molecules translate genetic code from DNA to make proteins, there is also a class called non-coding RNAs that does not.

"Saliva carries with it non-coding RNAs, microRNAs, piRNAs and circRNAs that are biomarkers for disease and health monitoring," said Wong, who also is associate dean of research at the UCLA School of Dentistry. "Had we not done this collaboration, we would never know that non-coding RNAs, microRNAs, piRNAs and circRNAs exist in saliva."

Their overriding conclusion is that saliva has tremendous medical and scientific value. In the not-too-distant future, dentists might be able to take saliva samples to analyze for a variety of diseases. And, Wong says, the research could lead to a new category of self-diagnostic devices. "This could indicate that wearable gear that informs you whether you have a disease -- even before you have any symptoms -- is almost here," he said.

The scientists, both members of UCLA's Jonsson Comprehensive Cancer Center, will continue their research, aiming to better understand the biology behind their findings, including the function of piRNAs.

"With a collaborator like Dr. Xiao, UCLA will continue to spearhead this science," Wong said. "Now we have the capability and technology to reach deeper and study non-coding RNA, which has never been done."
-end-
Co-authors of the research were UCLA postdoctoral scholars Jae Hoon Bahn and Qing Zhang in Xiao's laboratory; Feng Li, an assistant researcher in Wong's laboratory; Tak-Ming Chan, a former postdoctoral scholar in Xiao's laboratory; Xianzhi Lin, a postdoctoral scholar in Xiao's laboratory; and Yong Kim, a UCLA adjunct associate professor of dentistry.

The research was supported by the NIH's National Center for Advancing Translational Sciences (award UH2TR000923) through the Extracellular RNA Communication program.

University of California - Los Angeles

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.